Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiora Pharmaceuticals

3.09
-0.1067-3.34%
Post-market: 3.08-0.0066-0.21%17:18 EDT
Volume:26.98K
Turnover:80.29K
Market Cap:9.26M
PE:-1.08
High:3.16
Open:3.16
Low:2.85
Close:3.19
Loading ...
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 03, 2024

Major Issues Report

Form 8-K - Current report
Mar 27, 2024

Correspondence

Form CORRESP - Correspondence
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Jan 31, 2024

Major Issues Report

Form 8-K - Current report
Jan 16, 2024

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2023

Major Issues Report

Form 8-K - Current report